Recent Finacing
Recent Raise
Quidditas Therapeutics develops a recombination-based genome editing platform that cuts single- or double-stranded nucleic acids and pastes sequences of any length for gene replacement, bioproduction, stem cell and regenerative applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
